Hereditary Cancer Diagnostic Panel
![centogene-logo](/wp-content/uploads/2019/04/centogene-logo.png)
Assessing the hereditary risk for major cancer variants, including rare disease types.
Centogene Diagnostics tests will guide providers to indicate genetic mutation of hereditary nature by providing information from
BRCA 1 and BRCA 2 Whole gene sequencing
Clinical exome sequencing Cancer bearing gene of significance
Why Sayre-Centogene Collaboration
Global genotype-phenotype database for rare diseases CentoMD® and CentoPharma®
Advanced logistical solutions from sample sending (based on our CE-labeled CentoCard®) to report administration (using CentoPortal®)
High quality medical consultation
Quick turnaround time and fast reporting
For more information on centogene :
Please refer https://www.centogene.com/genetic-testing/disease-categories/oncogenetics.html or
Contact your local sales representative or Email us at info@sayretherapeutics.com